This site demonstrates one possible use of this domain. For acquisition, partnership, or investment inquiries, please use our contact link.
Ketalux - Ketamine Therapy Education
Accessibility

Accessibility Statement

Medically reviewed by: Pending medical review(draft)Last updated: June 1, 2026Evidence: Educational summary

Ketalux is committed to making our content usable for the widest possible audience, including people who use assistive technologies. We aim to conform to WCAG 2.1 Level AA.

What we do

  • Semantic HTML, landmarks, and headings for screen-reader navigation.
  • Sufficient color contrast and resizable text.
  • Descriptive alternative text on informative images.
  • Keyboard-accessible navigation and focus styles.
  • Plain-language summaries on clinical pages where possible.

Known limitations

Some embedded third-party content (such as research links or external resources) may not fully meet our accessibility standards. We work to provide accessible alternatives where possible.

Report a barrier

If you encounter an accessibility barrier on Ketalux, please email ira@idigits.com with the page URL, the issue, and the assistive technology you use. We aim to respond within five business days.

Educational use only. The content on this page is provided for general educational purposes and does not constitute medical advice, diagnosis, or treatment. Ketamine and related therapies carry risks and are appropriate only under qualified medical supervision. Always consult a licensed healthcare professional about your individual situation. Information may change as research evolves.